Spinifex: UPDATE 1-Novartis buys pain drug firm Spinifex for $200 mln upfront

BASEL, Switzerland, June 29 (Reuters) - Swiss drugmaker Novartis AG boosted its presence in pain management on Monday by agreeing to buy U.S.-Australian biotech firm Spinifex Pharmaceuticals, the companies said in separate statements on Monday.